Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR · Real-Time Price · USD
79.67
-2.89 (-3.50%)
At close: Oct 17, 2025, 4:00 PM EDT
80.13
+0.46 (0.58%)
After-hours: Oct 17, 2025, 5:51 PM EDT
Monopar Therapeutics Market Cap
Monopar Therapeutics has a market cap or net worth of $577.29 million as of October 17, 2025. Its market cap has increased by 3,281.14% in one year.
Market Cap
577.29M
Enterprise Value
524.15M
1-Year Change
3,281.14%
Ranking
Category
Stock Price
$79.67
Market Cap Chart
Since December 19, 2019, Monopar Therapeutics's market cap has increased from $276.16M to $577.29M, an increase of 109.04%. That is a compound annual growth rate of 13.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 577.29M | 330.28% |
| Dec 31, 2024 | 134.17M | 2,552.79% |
| Dec 29, 2023 | 5.06M | -83.48% |
| Dec 30, 2022 | 30.62M | -24.23% |
| Dec 31, 2021 | 40.42M | -42.33% |
| Dec 31, 2020 | 70.09M | -59.48% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 735.59B |
| Johnson & Johnson | 462.69B |
| AbbVie | 400.78B |
| UnitedHealth Group | 323.03B |
| AstraZeneca | 261.44B |
| Novo Nordisk | 254.14B |
| Novartis AG | 253.93B |
| Abbott Laboratories | 222.13B |